Ann: Positive CelGro Nerve Regeneration Results, page-67

Unfortunately, Orthocell has never been able to attract the bigger end of town. Sure we have had capital raises but even than they have sold out very quickly

Orthocell has Striate+ approved ready for partnering up soon enough, other product like Ortho-ATI, Celgro Nerve / Tendon and ACL- Rope getting ready for approvals and eventually partnerships

Compared to other biotech companies that are worth ten times what Orthocell is worth, with maybe one or two approvals, partnerships and always asking for more money through capital raises,
Orthocell is a dead set bargain

The biggest down side, retail hold way too many shares, you could say they have had a stranglehold over Orthocells share price. These guys are your common criminals selling down to buy cheaper, to start the cycle all over again, Rinse Repeat Rinse Repeat

Orthocell needs to partner up and show a return, Revenue before these big guys take notice and want in